Form 4 for NRXP NRX Pharmaceuticals, Inc.

Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-28 · accession 0001415889-22-011810 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-11-29	2022-11-28	NRXP	Flynn Patrick John	Dir	P - Purchase	$1.25	+10.0K	37.7K	+36%	+$12.5K
	2022-11-29	2022-11-28	NRXP	Flynn Patrick John	Dir	P - Purchase	$1.25	+1,750	1,750	New	+$2,188

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.001 per share	2022-11-28	P	A	2,500	$1.25	40,209	I By Trust	—	—	(F2) Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
2	Common	Common Stock, par value $0.001 per share	2022-11-28	P	A	1,750	$1.25	1,750	D	—	—
3	Common	Common Stock, par value $0.001 per share	2022-11-28	P	A	2,500	$1.24	40,209	I By Trust	—	—	(F4) Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
4	Common	Common Stock, par value $0.001 per share	2022-11-28	P	A	2,500	$1.25	37,709	I By Trust	—	—	(F3) Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
5	Common	Common Stock, par value $0.001 per share	2022-11-28	P	A	2,500	$1.25	37,709	I By Trust	—	—	(F1) Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.